Clinical Transplantation最新文献

筛选
英文 中文
Donation After Circulatory Versus Brain Death Among Adult Trauma Donors: A Retrospective Multicenter Study 成人创伤供者循环死亡与脑死亡后的捐赠:一项多中心回顾性研究
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-06 DOI: 10.1111/ctr.70740
Gina M. Berg, Constance McGraw Glass, David Acuna, Robert Madayag, William Tyler Crawley, Carlos H. Palacio, Kaysie Banton, David Bar-Or
{"title":"Donation After Circulatory Versus Brain Death Among Adult Trauma Donors: A Retrospective Multicenter Study","authors":"Gina M. Berg,&nbsp;Constance McGraw Glass,&nbsp;David Acuna,&nbsp;Robert Madayag,&nbsp;William Tyler Crawley,&nbsp;Carlos H. Palacio,&nbsp;Kaysie Banton,&nbsp;David Bar-Or","doi":"10.1111/ctr.70740","DOIUrl":"https://doi.org/10.1111/ctr.70740","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Donation after circulatory death (DCD) is an increasingly important source of organs and tissues, yet differences between DCD and donation after brain death (DBD) among trauma donors remain incompletely characterized. We compared DCD and DBD donors among trauma patients who proceeded to donation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Adult trauma patients who died during hospitalization across four trauma centers from January 1, 2016, through July 15, 2022, were retrospectively screened; the analytic cohort comprised patients who proceeded to donation. Multivariable logistic regression examined factors associated with DCD versus DBD among donors.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Among 173 donors, 90 (52%) were DCD and 83 (48%) were DBD. Compared with DBD donors, DCD donors were older (median 52 vs. 31 years, <i>p</i> = 0.006), more often White (78% vs. 47%, <i>p</i> &lt; 0.001), had fewer severe head/neck injuries (AIS ≥ 3: 61% vs. 87%, <i>p</i> &lt; 0.001), higher admission GCS (13–15: 24% vs. 8%, <i>p</i> = 0.003), and were less often admitted to the ICU (79% vs. 98%, <i>p</i> = 0.002). DCD donors had a lower median number of organs and tissues recovered (2 [IQR 1–3] vs. 3 [2–4], <i>p</i> &lt; 0.001). After adjustment, GCS 9–15 vs. 3–8 (AOR 3.62, 95% CI (1.22–10.77)), White race (5.41, (2.24–13.06)), head/neck AIS ≤2 vs. ≥ 3 (5.15, (1.99–13.34)), and trauma center were independently associated with DCD.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Among trauma donors, DCD and DBD donors differed in neurologic injury severity, hospital course, and organ and tissue recovery patterns. Studies that include all potential trauma donors are needed to identify factors that may influence referral, authorization, and conversion.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149356314","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Long-Term Outcomes With 100 Dual Kidney Transplants From Adult Deceased Donors: Negative Effect of Changes in Kidney Allocation 100例成人已故供者双肾移植的长期结果:肾脏分配变化的负面影响
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-06 DOI: 10.1111/ctr.70736
Arianna Cabrales, Rana Kumar, Giuseppe Orlando, Christopher Webb, Emily McCracken, Colleen L. Jay, Alan C. Farney, Robert J. Stratta
{"title":"Long-Term Outcomes With 100 Dual Kidney Transplants From Adult Deceased Donors: Negative Effect of Changes in Kidney Allocation","authors":"Arianna Cabrales,&nbsp;Rana Kumar,&nbsp;Giuseppe Orlando,&nbsp;Christopher Webb,&nbsp;Emily McCracken,&nbsp;Colleen L. Jay,&nbsp;Alan C. Farney,&nbsp;Robert J. Stratta","doi":"10.1111/ctr.70736","DOIUrl":"10.1111/ctr.70736","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Introduction</h3>\u0000 \u0000 <p>Dual kidney transplantation (DKT) may expand the donor pool from adult donors with limited renal functional capacity.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Single center retrospective review of outcomes in DKT recipients. All patients received antibody induction with tacrolimus/mycophenolate/steroids. Recipient selection was based on low immunological risk (low PRA, primary transplant), limited nephron need (older age, lower BMI), and out-of-sequence allocation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Over 24 years, 100 DKTS were performed. Mean KDPI was 85%; 88 (88%) were managed with hypothermic machine preservation; 45 (45%) were imported, and mean cold ischemia time was 26.8 ± 7.4 h for the first kidney. Mean donor and recipient ages were 59.7 ± 17.5 and 60.0 ± 14.8 years, respectively. Mean pre-DKT waiting and dialysis times were 11.3 ± 22 months and 26.5 ± 35 months, respectively. Delayed graft function occurred in 28% (2 primary nonfunction). At 12 months, mean serum creatinine was 1.49 ± 2.0 mg/dl and GFR 55 ± 25 mL/min/1.73m<sup>2</sup> in DKT recipients. 79 DKT patients (79%) had at least 10-year follow-up. Compared to 428 concurrent single KTs from high KDPI donors, patient and graft survival rates and renal function were superior in the DKT group; death-censored graft survival was not different. Projected kidney half-lives for DKT and high KDPI single KTs were 7.8 years and 5.9 years, respectively. With changes in kidney allocation, the number of DKTs decreased from 9.0 to 2.7 to 1.6/year.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>DKTs using kidneys from medically complex donors that otherwise might be discarded provide acceptable long-term outcomes and can improve access for older recipients. However, changes in allocation have had a negative effect on DKT activity.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341141","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prof. Gerhard Opelz 1944–2026. The Genius Behind the Collaborative Transplant Study (CTS) 格哈德·奥佩尔兹教授,1944-2026。协同移植研究(CTS)背后的天才
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-05 DOI: 10.1111/ctr.70738
Robert Peter Gale
{"title":"Prof. Gerhard Opelz 1944–2026. The Genius Behind the Collaborative Transplant Study (CTS)","authors":"Robert Peter Gale","doi":"10.1111/ctr.70738","DOIUrl":"https://doi.org/10.1111/ctr.70738","url":null,"abstract":"","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149356247","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Are You Ready to Tackle the Troll? New Guidelines for the Management of Posttransplant Cytomegalovirus Infection 你准备好应对巨魔了吗?移植后巨细胞病毒感染处理新指南。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-05 DOI: 10.1111/ctr.70717
Marcus Pereira
{"title":"Are You Ready to Tackle the Troll? New Guidelines for the Management of Posttransplant Cytomegalovirus Infection","authors":"Marcus Pereira","doi":"10.1111/ctr.70717","DOIUrl":"10.1111/ctr.70717","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <p>Posttransplant cytomegalovirus (CMV) infection has long been known as the “troll of transplantation”—a hidden threat that can emerge after solid organ transplant (SOT) or hematopoietic cell transplant (HCT) and jeopardize patient well-being. CMV infection is associated with increased morbidity, mortality, graft loss, and hospitalization, as well as a substantial patient burden that many clinicians may underappreciate. Management becomes even more challenging when infection is refractory or resistant to treatment. To improve outcomes, healthcare professionals must be able to identify patients at risk for CMV infection and refractory/resistant disease, interpret diagnostic findings, apply updated guideline recommendations, and individualize antiviral therapy using current evidence. This comic-based, expert-led case activity follows a transplant recipient from the initial presentation of CMV infection through refractory/resistant disease, with patient perspectives woven throughout. Expert faculty perspectives and patient commentary will explore the clinical and psychosocial burden of CMV infection, risk assessment, diagnosis, treatment selection, resistance testing, and shared decision-making in posttransplant CMV care. To view this activity and obtain CME/CE credit, visit www.cmeologyce.org/cmv.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ctr.70717","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341139","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Interventions to Increase Organ Donation: A Systematic Review 增加器官捐献的干预措施:系统综述。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-05 DOI: 10.1111/ctr.70741
Shamatanni Chowdhury, Abigail H. Coulter, Madeline McGinnis, Tyler C. Melton, Brittany A. Shelton
{"title":"Interventions to Increase Organ Donation: A Systematic Review","authors":"Shamatanni Chowdhury,&nbsp;Abigail H. Coulter,&nbsp;Madeline McGinnis,&nbsp;Tyler C. Melton,&nbsp;Brittany A. Shelton","doi":"10.1111/ctr.70741","DOIUrl":"10.1111/ctr.70741","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>Access to organ transplantation is constrained by an insufficient supply of donor organs. Although many interventions address donation-related knowledge and attitudes, fewer assess outcomes such as registration, authorization, or donation.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Objective</h3>\u0000 \u0000 <p>To synthesize evidence on United States–based interventions designed to increase organ donation among adults.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>Six databases were searched for English-language studies published between 2010 and 2023. Eligible designs included randomized trials, quasi-experimental studies, cohort studies, and pre–post studies reporting donor registration, authorization or consent, donation rates, or number of donors. Two reviewers independently screened and extracted records, and three reviewers completed Joanna Briggs Institute risk-of-bias (JBI) assessments. Findings were synthesized narratively.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Of 2206 identified records, 36 studies met the inclusion criteria: 13 randomized or cluster-randomized studies, 22 quasi-experimental studies, and one cohort study. Interventions were implemented in motor vehicle offices, healthcare settings, workplaces, universities, churches, community organizations, and online platforms. Effects were mixed. Immediate registration opportunities, interpersonal or peer engagement, staff involvement, and system-level workflow changes were more consistently associated with increased registration, designation, consent, and donation rates. Passive interventions with written materials and lower-intensity media interventions generally produced smaller or nonsignificant effects. Common limitations included lack of blinding, unclear allocation concealment, baseline differences, absence of concurrent controls, and residual confounding.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusions</h3>\u0000 \u0000 <p>Interventions that reduce logistical barriers and actively engage participants appear more promising than education alone. Rigorous controlled studies are needed to identify scalable strategies, determine which approaches work across populations and settings, and inform efforts to narrow gaps between transplant demand and organ supply.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-05","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/ctr.70741","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149341140","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Transplantation of Hepatitis B Surface Antigen Positive or Viremic Kidneys: A Systematic Review and Meta-Analysis 乙型肝炎表面抗原阳性或病毒血症肾移植:系统回顾和荟萃分析。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-03 DOI: 10.1111/ctr.70733
Dhruv Ahuja, Beatrice P. Concepcion, Yuhong Yuan, Rachel Forbes, James L. Rogers, Helen S. Te, Yvonne El Kassis
{"title":"Transplantation of Hepatitis B Surface Antigen Positive or Viremic Kidneys: A Systematic Review and Meta-Analysis","authors":"Dhruv Ahuja,&nbsp;Beatrice P. Concepcion,&nbsp;Yuhong Yuan,&nbsp;Rachel Forbes,&nbsp;James L. Rogers,&nbsp;Helen S. Te,&nbsp;Yvonne El Kassis","doi":"10.1111/ctr.70733","DOIUrl":"10.1111/ctr.70733","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Purpose</h3>\u0000 \u0000 <p>This systematic review and meta-analysis examines the evidence related to the use of HBV positive kidneys into non-viremic kidney transplant recipients (KTRs).</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods</h3>\u0000 \u0000 <p>We searched PubMed and Embase through November 2025 and identified studies of recipients of hepatitis B surface antigen positive (HBsAg+) or viremic kidneys. Studies with a comparison group of KTRs of HBV negative kidneys that reported on patient and allograft survivals were included in the meta-analysis. The risk ratios (RR) for patient and allograft survivals were pooled to obtain the estimate and 95% confidence interval, at 1-, 3-, and 5-years post-transplant. Viral transmission including HBsAg development, HBV viremia, or hepatitis was also reviewed.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results</h3>\u0000 \u0000 <p>Eleven studies were included in the systematic review and 6 in the meta-analysis. They included 638 KTRs of HBV positive kidneys and 2800 recipients of HBsAg negative non viremic kidneys. At 1, 3, and 5 years, the RR of allograft survival was not statistically different between the 2 groups and was 1 [0.98–1.01], 1.01 [0.98–1.04], and 1.00 [0.91–1.09] respectively. Similarly, the RR of patient survival was comparable between the 2 groups. The rate of HBV transmission was low (4.94%), especially when prophylaxis was used and when recipients were immune pre transplant.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>Kidneys from HBV infected donors confer similar patient and allograft survival than those from HBV negative donors. They may be used to expand the donor pool, in immune KTRs and with appropriate prophylaxis, in light of this emerging evidence of safety with very low reported rates of transmission.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-03","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13731160/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149318757","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cellular and Histopathological Hallmarks of Acute and Chronic Rejection in Vascular Composite Allografts: A Systematic Review. 血管复合异体移植物急性和慢性排斥反应的细胞和组织病理学特征:系统综述。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-01 DOI: 10.1111/ctr.70744
Leonard Knoedler, Tobias Niederegger, Jakob Fenske, Murtaja Satea, Alessia Taggiasco, Guilherme F Machado, Thomas Schaschinger, Romane Gaillard, Jadyn Heffern, Jasper Iske, Maximilian Richter, Max Heiland, Curtis L Cetrulo, Haïzam Oubari, Alexandre G Lellouch
{"title":"Cellular and Histopathological Hallmarks of Acute and Chronic Rejection in Vascular Composite Allografts: A Systematic Review.","authors":"Leonard Knoedler, Tobias Niederegger, Jakob Fenske, Murtaja Satea, Alessia Taggiasco, Guilherme F Machado, Thomas Schaschinger, Romane Gaillard, Jadyn Heffern, Jasper Iske, Maximilian Richter, Max Heiland, Curtis L Cetrulo, Haïzam Oubari, Alexandre G Lellouch","doi":"10.1111/ctr.70744","DOIUrl":"10.1111/ctr.70744","url":null,"abstract":"<p><strong>Background: </strong>VCA provides major reconstructive benefits but is limited by frequent rejection. Given the high immunogenicity of skin and mucosa, this systematic review synthesizes the cellular, immunophenotypic, and histopathological features of acute rejection (AR) and chronic rejection (CR) across all VCA types to improve surveillance and long-term graft outcomes.</p><p><strong>Methods: </strong>RISMA-compliant systematic review (PROSPERO CRD420251146481) of PubMed, Embase, and Cochrane identified original human VCA studies reporting histopathologic/immunologic findings in acute and/or chronic rejection. Data on rejection rates, immune cell profiles, and tissue injury patterns were extracted but heterogeneity precluded meta-analysis; categorical comparisons used chi-squared or Fisher's exact tests.</p><p><strong>Results: </strong>Across 51 studies (2000-2025), 208 VCA rejection episodes were reported: AR 177 (85%) and CR 31 (15%), with distributions differing by VCA type (p < 0.0001). AR was most common in FVCA 102 (58%) and UE VCA 48 (27%); CR in FVCA 19 (61%) and KVCA 7 (23%). AR was mainly T-cell-driven (CD8+ 49%, CD4+ 47%, CD3+ 35%), while CR was characterized by endothelial involvement/graft vasculopathy (n = 10, 20%) and fibrosis (n = 6, 12%). Histopathology was reported in 78% of studies, most often associated with cellular infiltrates 73%, perivascular lymphocytic infiltrates 71%, epidermal apoptosis/necrosis 49%, interface dermatitis 25% and C4d deposits 18%.</p><p><strong>Conclusions: </strong>AR and CR in VCA have distinct, heterogeneous patterns that vary by graft type. Limited reported data, especially for CR, highlight the need for standardized criteria and multicenter longitudinal studies. Surveillance with integrated histomolecular profiling may enable earlier detection and more targeted immunomodulation to improve long-term outcomes.</p>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370084","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta-analysis. 阿司匹林对心脏移植后死亡率和同种异体移植血管病变的影响:系统回顾和荟萃分析。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-01 DOI: 10.1111/ctr.70742
Noémie Fournier, Panagiotis Antiochos, Baris Gencer, Anna Nowacka, Tamila Abdurashidova, Patrick Yerly, Philippe Meyer, Valentina Rancati, Zied Ltaief, Olivier Muller, Matthias Kirsch, Roger Hullin, Henri Lu
{"title":"Impact of Aspirin Use on Mortality and Cardiac Allograft Vasculopathy After Heart Transplantation: A Systematic Review and Meta-analysis.","authors":"Noémie Fournier, Panagiotis Antiochos, Baris Gencer, Anna Nowacka, Tamila Abdurashidova, Patrick Yerly, Philippe Meyer, Valentina Rancati, Zied Ltaief, Olivier Muller, Matthias Kirsch, Roger Hullin, Henri Lu","doi":"10.1111/ctr.70742","DOIUrl":"10.1111/ctr.70742","url":null,"abstract":"<p><strong>Background: </strong>Cardiac allograft vasculopathy (CAV) remains a major cause of late graft failure and morbidity among heart transplant (HTx) recipients. Aspirin is currently assigned a Class IIb recommendation for CAV prevention, reflecting the limited evidence supporting its clinical benefit. We conducted a systematic review and meta-analysis to assess the association between aspirin use and clinical outcomes in HTx recipients (PROSPERO ID: CRD420261399873).</p><p><strong>Methods: </strong>Outcomes of interest included all-cause mortality and CAV-related clinical outcomes (graft dysfunction or CAV-related death). Literature searches were conducted through December 2025 in PubMed and EMBASE. Studies comparing HTx recipients treated with aspirin versus no aspirin were included. Hazard ratios (HRs) and 95% confidence intervals (CIs) were meta-analyzed across studies.</p><p><strong>Results: </strong>Five observational studies were included, comprising four adult cohorts and one pediatric cohort. Participants were predominantly male (66.6%), with a mean age of ≈50 years in the four adult studies and 7.4 years in the sole pediatric study. Aspirin use was associated with significantly lower all-cause mortality (four studies, HR 0.31 [95% CI: 0.15-0.67]). No statistically significant association was observed with CAV-related clinical outcomes (HR 0.42 [95% CI: 0.10-1.77]).</p><p><strong>Conclusions: </strong>In HTx recipients, aspirin use was associated with lower all-cause mortality, while no significant association was observed in the exploratory analysis of CAV-related clinical outcomes. These findings should be interpreted cautiously given the observational design, substantial heterogeneity, and potential residual and time-related biases. Prospective studies are needed to determine the efficacy and safety of aspirin after HTx.</p>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC13744394/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149370085","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Controlled Hypothermic Storage and Time-Shifting in Lung Transplantation: A Single-Center Study. 肺移植中的受控低温储存和时间转移:一项单中心研究。
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-01 DOI: 10.1111/ctr.70684
Andrew Keogan, Theodore Lin, Mark Shacker, Lucia Chang, Lucas Wang, Rajat Walia, Ross M Bremner, Jasmine Huang, Nathan Zwintscher, Michael A Smith, Lara W Schaheen
{"title":"Controlled Hypothermic Storage and Time-Shifting in Lung Transplantation: A Single-Center Study.","authors":"Andrew Keogan, Theodore Lin, Mark Shacker, Lucia Chang, Lucas Wang, Rajat Walia, Ross M Bremner, Jasmine Huang, Nathan Zwintscher, Michael A Smith, Lara W Schaheen","doi":"10.1111/ctr.70684","DOIUrl":"https://doi.org/10.1111/ctr.70684","url":null,"abstract":"<p><strong>Purpose: </strong>This study compared lung transplant outcomes between cases using controlled hypothermic storage (CHS) donor lung transport with ischemic times > 6 h and those using cold static storage (CSS) transport with ischemic times < 6 h.</p><p><strong>Methods: </strong>We retrospectively reviewed lung transplantations performed at our center from September 15, 2014 to March 29, 2025, excluding ex vivo lung perfusion, single-lung, redo, and multi-organ cases. Perioperative outcomes were assessed using univariate, multivariable, survival, and propensity-matched analyses.</p><p><strong>Results: </strong>Among 770 recipients, 87 (11.3%) and 683 (88.7%) received lungs preserved using CHS and CSS, respectively. In the CHS group, ischemic times were significantly longer (median, 11.0 vs. 4.3 h, p < 0.001), and transport distances were greater (median, 750 vs. 219 nautical miles, p < 0.001). CHS was associated with higher rates of daytime transplantation (79% vs. 51%, p < 0.001) and delayed chest closure (22% vs. 13%, p = 0.023). Primary graft dysfunction grade 3 (PGD3) at 72 h was lower in the CHS group (13% vs. 26%, p = 0.019), and CHS was independently associated with a lower risk of PGD3 on multivariable analysis (aOR 0.38, 95% CI 0.17-0.83, p = 0.016). In a propensity-matched analysis, PGD3 at 72 h was lower in the CHS group, but the difference did not reach statistical significance (12% vs. 26%, p = 0.059). Kaplan-Meier analysis demonstrated similar survival between groups (p = 0.53).</p><p><strong>Conclusion: </strong>CHS enables the safe extension of ischemic time beyond conventional limits, facilitating broader geographic access and a shift toward increased daytime transplantation. Short-term outcomes were comparable to those of CSS, with a lower incidence of PDG3.</p>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149377831","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation of a Standardized Treatment Regimen for Antibody Mediated Rejection Following Lung Transplantation 肺移植后抗体介导的排斥反应标准化治疗方案的评价
IF 1.8 4区 医学
Clinical Transplantation Pub Date : 2026-11-01 DOI: 10.1111/ctr.70737
Richard W. Lincoln, Elizabeth Hipkiss, Keith A. Fester, Sahil Sanghani, Chad A. Witt, Spenser January
{"title":"Evaluation of a Standardized Treatment Regimen for Antibody Mediated Rejection Following Lung Transplantation","authors":"Richard W. Lincoln,&nbsp;Elizabeth Hipkiss,&nbsp;Keith A. Fester,&nbsp;Sahil Sanghani,&nbsp;Chad A. Witt,&nbsp;Spenser January","doi":"10.1111/ctr.70737","DOIUrl":"https://doi.org/10.1111/ctr.70737","url":null,"abstract":"<div>\u0000 \u0000 \u0000 <section>\u0000 \u0000 <h3> Background</h3>\u0000 \u0000 <p>The treatment of antibody mediated rejection (AMR) in lung transplant recipients (LTRs) requires a multi-modal approach targeting various pathways in the immune system. There currently is no consensus on what the standard therapy for AMR in LTRs should be. This study evaluates the efficacy of a standardized treatment protocol versus a non-standardized approach.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Methods:</h3>\u0000 \u0000 <p>This retrospective, single-center study evaluated LTRs treated for AMR with either a standard treatment approach consisting of methylprednisolone, carfilzomib, anti-thymocyte globulin, tocilizumab, and intravenous immunoglobulins or a non-standardized approach. The primary outcome was the incidence of graft loss within 1 year of AMR treatment. Secondary endpoints included the incidence of infections and chronic lung allograft dysfunction (CLAD) within 1 year from AMR treatment.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Results:</h3>\u0000 \u0000 <p>Thirteen patients were included in the standard and 38 patients in the non-standard cohorts. Median time from transplant to AMR was 606 (160–935) days in the standard cohort and 314 (92–541) days in the non-standard cohort (<i>p</i> = 0.125). Graft loss within 1 year from AMR was 30.8% and 39.5% for the standard and non-standard cohorts, respectively (<i>p</i> = 0.416). The incidence of CLAD (69.2% vs 68% [<i>p</i> = 0.619]) and infections (53.8% vs 65.8% [<i>p</i> = 0.504]) were similar in the standard and non-standard cohorts.</p>\u0000 </section>\u0000 \u0000 <section>\u0000 \u0000 <h3> Conclusion</h3>\u0000 \u0000 <p>In this retrospective study, there was numerically better 1 year graft survival in the standard cohort vs the non-standard cohort but no difference in incidence of CLAD and infections post AMR.</p>\u0000 </section>\u0000 </div>","PeriodicalId":10467,"journal":{"name":"Clinical Transplantation","volume":"40 11","pages":""},"PeriodicalIF":1.8,"publicationDate":"2026-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149311319","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书